Kim Won Gu, Kim Won Bae, Woo Gyeongji, Kim Hyejin, Cho Yumi, Kim Tae Yong, Kim Sun Wook, Shin Myung Hee, Park Jin Woo, Park Hai Lin, Oh Kyungwon, Chung Jae Hoon
Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Division of Health and Nutrition Survey, Korea Centers for Disease Control and Prevention, Cheongju, Korea.
Endocrinol Metab (Seoul). 2017 Mar;32(1):106-114. doi: 10.3803/EnM.2017.32.1.106. Epub 2017 Jan 23.
No nationwide epidemiological study evaluating the prevalence of subclinical and overt forms of hypothyroidism and hyperthyroidism has yet been conducted in Korea. This study aimed to evaluate the reference range of serum thyroid stimulating hormone (TSH) and the national prevalence of thyroid dysfunctions in Korea.
Nation-wide cross-sectional data were analyzed from a representative sample of the civilian, non-institutionalized Korean population (n=6,564) who underwent blood testing for thyroid function and anti-thyroid peroxidase antibody (TPOAb) as part of the Korea National Health and Nutrition Examination Survey VI (2013 to 2015).
The reference interval of serum TSH in the Korean reference population was 0.62 to 6.68 mIU/L. Based on this reference interval, the prevalence of overt and subclinical hypothyroidism was 0.73% (males 0.40%, females 1.10%) and 3.10% (males 2.26%, females 4.04%), respectively. The prevalence of hypothyroidism increased with age until the age group between 50 to 59 years. Positive TPOAb were found in 7.30% of subjects (males 4.33%, females 10.62%). The prevalence of overt and subclinical hypothyroidism TPOAb-positive subjects was 5.16% and 10.88%, respectively. The prevalence of overt and subclinical hyperthyroidism was 0.54% (males 0.30%, females 0.81%) and 2.98% (males 2.43%, females, 3.59%), respectively.
The Serum TSH reference levels in the Korean population were higher than the corresponding levels in Western countries. Differences were found in the prevalence of hypothyroidism and hyperthyroidism according to age, sex, and TPOAb positivity. This study provides important baseline information for understanding patterns of thyroid dysfunction and diseases in Korea.
韩国尚未开展全国性的流行病学研究来评估亚临床和显性甲状腺功能减退症及甲状腺功能亢进症的患病率。本研究旨在评估韩国血清促甲状腺激素(TSH)的参考范围以及甲状腺功能障碍的全国患病率。
对韩国全国健康与营养检查调查VI(2013年至2015年)中接受甲状腺功能和抗甲状腺过氧化物酶抗体(TPOAb)血液检测的非机构化韩国平民代表性样本(n = 6,564)的全国横断面数据进行分析。
韩国参考人群中血清TSH的参考区间为0.62至6.68 mIU/L。基于此参考区间,显性和亚临床甲状腺功能减退症的患病率分别为0.73%(男性0.40%,女性1.10%)和3.10%(男性2.26%,女性4.04%)。甲状腺功能减退症的患病率随年龄增长直至50至59岁年龄组。7.30%的受试者检测到TPOAb阳性(男性4.33%,女性10.62%)。TPOAb阳性受试者中显性和亚临床甲状腺功能减退症的患病率分别为5.16%和10.88%。显性和亚临床甲状腺功能亢进症的患病率分别为0.54%(男性0.30%,女性0.81%)和2.98%(男性2.43%,女性3.59%)。
韩国人群的血清TSH参考水平高于西方国家的相应水平。根据年龄、性别和TPOAb阳性情况,甲状腺功能减退症和甲状腺功能亢进症的患病率存在差异。本研究为了解韩国甲状腺功能障碍和疾病模式提供了重要的基线信息。